Published in J Bacteriol on September 01, 2006
Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev (2009) 4.11
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology (2008) 1.52
The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis. J Bacteriol (2009) 1.41
Mutational activation of niche-specific genes provides insight into regulatory networks and bacterial function in a complex environment. Proc Natl Acad Sci U S A (2007) 1.35
Regulation of flagellar motility during biofilm formation. FEMS Microbiol Rev (2013) 1.28
Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int J Mol Sci (2013) 1.09
ChIP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa. PLoS Pathog (2014) 1.07
The sigma factor AlgU plays a key role in formation of robust biofilms by nonmucoid Pseudomonas aeruginosa. J Bacteriol (2010) 1.02
The Gac-Rsm and SadB signal transduction pathways converge on AlgU to downregulate motility in Pseudomonas fluorescens. PLoS One (2012) 1.00
Imaging and analysis of Pseudomonas aeruginosa swarming and rhamnolipid production. Appl Environ Microbiol (2011) 0.98
Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation. Pathogens (2014) 0.95
Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia. Microbiology (2009) 0.94
The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. PLoS One (2007) 0.94
The transcription factor AmrZ utilizes multiple DNA binding modes to recognize activator and repressor sequences of Pseudomonas aeruginosa virulence genes. PLoS Pathog (2012) 0.94
Bacterial adaptation during chronic infection revealed by independent component analysis of transcriptomic data. BMC Microbiol (2011) 0.93
Recent developments for Pseudomonas vaccines. Hum Vaccin (2011) 0.91
Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient. Front Microbiol (2011) 0.90
AmrZ modulates Pseudomonas aeruginosa biofilm architecture by directly repressing transcription of the psl operon. J Bacteriol (2013) 0.90
Thermo-regulation of genes mediating motility and plant interactions in Pseudomonas syringae. PLoS One (2013) 0.88
AmrZ beta-sheet residues are essential for DNA binding and transcriptional control of Pseudomonas aeruginosa virulence genes. J Bacteriol (2010) 0.88
AmrZ is a global transcriptional regulator implicated in iron uptake and environmental adaption in P. fluorescens F113. BMC Genomics (2014) 0.85
Evidence for sigma factor competition in the regulation of alginate production by Pseudomonas aeruginosa. PLoS One (2013) 0.84
Effect of high temperature on Pseudomonas putida NBRI0987 biofilm formation and expression of stress sigma factor RpoS. Curr Microbiol (2008) 0.83
flhDC, but not fleQ, regulates flagella biogenesis in Azotobacter vinelandii, and is under AlgU and CydR negative control. Microbiology (2008) 0.82
BswR controls bacterial motility and biofilm formation in Pseudomonas aeruginosa through modulation of the small RNA rsmZ. Nucleic Acids Res (2014) 0.80
The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation. PLoS One (2014) 0.79
Novel genes involved in Pseudomonas fluorescens Pf0-1 motility and biofilm formation. Appl Environ Microbiol (2012) 0.79
Crystallization of Pseudomonas aeruginosa AmrZ protein: development of a comprehensive method for obtaining and optimization of protein-DNA crystals. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78
Multiple phenotypic changes associated with large-scale horizontal gene transfer. PLoS One (2014) 0.78
The Pseudomonas aeruginosa AmrZ C-terminal domain mediates tetramerization and is required for its activator and repressor functions. Environ Microbiol Rep (2015) 0.77
The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes. Front Cell Infect Microbiol (2014) 0.77
Development of a Novel Method for Analyzing Pseudomonas aeruginosa Twitching Motility and Its Application to Define the AmrZ Regulon. PLoS One (2015) 0.76
Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung. Infect Immun (2016) 0.76
Pseudomonas aeruginosa AmrZ Binds to Four Sites in the algD Promoter, Inducing DNA-AmrZ Complex Formation and Transcriptional Activation. J Bacteriol (2016) 0.75
AlgU Controls Expression of Virulence Genes in Pseudomonas syringae pv. tomato DC3000. J Bacteriol (2016) 0.75
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A (1979) 44.75
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol (1999) 6.06
Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol (1999) 4.26
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun (1994) 3.83
Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun (1998) 3.43
A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.05
The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol (2001) 2.87
Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol (2004) 2.66
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol (2005) 2.49
A transcriptional activator, FleQ, regulates mucin adhesion and flagellar gene expression in Pseudomonas aeruginosa in a cascade manner. J Bacteriol (1997) 2.29
Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect Immun (1987) 1.96
Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 1.85
Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J Bacteriol (1999) 1.75
Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros (2005) 1.71
The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili. J Bacteriol (2006) 1.63
Sigma factor-anti-sigma factor interaction in alginate synthesis: inhibition of AlgT by MucA. J Bacteriol (1996) 1.59
The sodium-driven flagellar motor controls exopolysaccharide expression in Vibrio cholerae. J Bacteriol (2004) 1.58
Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun (2004) 1.56
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun (1990) 1.51
Identification and characterization of AlgZ, an AlgT-dependent DNA-binding protein required for Pseudomonas aeruginosa algD transcription. Mol Microbiol (1996) 1.50
Mutations in the extracellular protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun (2000) 1.50
FleQ, the major flagellar gene regulator in Pseudomonas aeruginosa, binds to enhancer sites located either upstream or atypically downstream of the RpoN binding site. J Bacteriol (2002) 1.36
Sinorhizobium meliloti ExoR and ExoS proteins regulate both succinoglycan and flagellum production. J Bacteriol (2004) 1.31
The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ. J Bacteriol (2005) 1.26
Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol (2004) 1.24
Regulation of capsule synthesis and cell motility in Salmonella enterica by the essential gene igaA. Genetics (2002) 1.24
Pseudomonas aeruginosa AlgZ, a ribbon-helix-helix DNA-binding protein, is essential for alginate synthesis and algD transcriptional activation. Mol Microbiol (1999) 1.22
Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol (2004) 1.16
Control of Pseudomonas aeruginosa algZ expression by the alternative sigma factor AlgT. J Bacteriol (2003) 1.09
Binding of Pseudomonas aeruginosa AlgZ to sites upstream of the algZ promoter leads to repression of transcription. J Bacteriol (2005) 1.05
Biochemical and genetic analysis of operator contacts made by residues within the beta-sheet DNA binding motif of Mnt repressor. EMBO J (1992) 1.04
Domains of Mnt repressor: roles in tetramer formation, protein stability, and operator DNA binding. Biochemistry (1995) 1.00
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol (2004) 3.39
The EPS matrix: the "house of biofilm cells". J Bacteriol (2007) 3.38
Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog (2009) 2.85
Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol (2007) 2.74
Analysis of Pseudomonas aeruginosa conditional psl variants reveals roles for the psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol (2006) 2.53
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol (2005) 2.49
Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev (2002) 2.27
Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol (2010) 2.24
Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J Bacteriol (2009) 2.22
The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog (2011) 2.04
Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol Rev (2012) 2.00
Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol Microbiol (2009) 1.91
The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol (2011) 1.69
Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA. Mol Microbiol (2010) 1.66
The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili. J Bacteriol (2006) 1.63
Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol (2007) 1.37
Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility. J Bacteriol (2002) 1.37
Self-produced exopolysaccharide is a signal that stimulates biofilm formation in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2012) 1.36
The alternative sigma factor AlgT represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of fleQ. J Bacteriol (2005) 1.26
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol (2011) 1.25
Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol (2004) 1.16
Role of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis. J Bacteriol (2006) 1.13
The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol (2012) 1.13
A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Infect Immun (2009) 1.12
Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing. Cancer Immunol Immunother (2009) 1.05
The BvgAS signal transduction system regulates biofilm development in Bordetella. J Bacteriol (2005) 1.05
Binding of Pseudomonas aeruginosa AlgZ to sites upstream of the algZ promoter leads to repression of transcription. J Bacteriol (2005) 1.05
Static growth of mucoid Pseudomonas aeruginosa selects for non-mucoid variants that have acquired flagellum-dependent motility. Microbiology (2002) 1.04
The sigma factor AlgU plays a key role in formation of robust biofilms by nonmucoid Pseudomonas aeruginosa. J Bacteriol (2010) 1.02
The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter. J Bacteriol (2007) 1.01
A spider web strategy of type IV pili-mediated migration to build a fibre-like Psl polysaccharide matrix in Pseudomonas aeruginosa biofilms. Environ Microbiol (2013) 1.01
The Pseudomonas aeruginosa exopolysaccharide Psl facilitates surface adherence and NF-kappaB activation in A549 cells. MBio (2010) 0.98
Control of bacterial biofilms with marine alkaloid derivatives. Mol Biosyst (2008) 0.97
Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated. Environ Microbiol (2012) 0.95
Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model. Infect Immun (2011) 0.94
The transcription factor AmrZ utilizes multiple DNA binding modes to recognize activator and repressor sequences of Pseudomonas aeruginosa virulence genes. PLoS Pathog (2012) 0.94
Pseudomonas aeruginosa AlgR regulates type IV pilus biosynthesis by activating transcription of the fimU-pilVWXY1Y2E operon. J Bacteriol (2008) 0.92
Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage. PLoS One (2011) 0.91
AmrZ modulates Pseudomonas aeruginosa biofilm architecture by directly repressing transcription of the psl operon. J Bacteriol (2013) 0.90
First evidence of sternal wound biofilm following cardiac surgery. PLoS One (2013) 0.89
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function. Microbiol Spectr (2015) 0.89
AmrZ beta-sheet residues are essential for DNA binding and transcriptional control of Pseudomonas aeruginosa virulence genes. J Bacteriol (2010) 0.88
Biofilms and infectious diseases: biology to mathematics and back again. FEMS Microbiol Lett (2011) 0.86
The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. BMC Cancer (2010) 0.85
The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa. Environ Microbiol Rep (2015) 0.83
The role of biofilms in airway disease. Semin Respir Crit Care Med (2003) 0.79
Crystallization of Pseudomonas aeruginosa AmrZ protein: development of a comprehensive method for obtaining and optimization of protein-DNA crystals. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78
Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice. BMC Cancer (2009) 0.77
Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. BMC Cancer (2010) 0.75